CMS (Centers for Medicare and Medicaid Services) firm on lead poisoning screening for children
This article was originally published in Clinica
The Centers for Medicare and Medicaid Services (CMS) said it will not loosen government regulations that require poor children to be screened for lead poisoning. "We have no intention of changing the policy," CMS administrator Thomas Scully told the Washington Post last week.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.